Company intelligence / Profile preview

Palisade Bio

Carlsbad, California, United Statespalisadebio.com ↗
Ownership
Public · PALI
Employees
~8
Development stage
Phase 2
01

Overview

Palisade Bio's lead candidate, PALI-2108, a prodrug PDE4 inhibitor, has completed single ascending dose (SAD), multiple ascending dose (MAD), food effect studies and first UC patient dosing in Phase 1a/b. Topline data are expected in the first half of 2025. The company also has a program targeting fibrostenotic Crohn’s disease at the discovery/early clinical stage. Both programs aim to address unmet needs in immune-mediated inflammatory and fibrotic diseases by improving efficacy and safety over existing therapies through precision targeting.

Therapeutic areas
Gastroenterology
Modalities
Small molecules (prodrug PDE4 inhibitors)
Industry
Biotech
02

Drug pipeline

7 assets

PALI-2108

2

6 more assets in the full pipeline.

03

Partnerships

Giiant Pharma Inc. (research collaboration and license agreement)Regents of the University of California (license agreement)Newsoara Biopharma Co., Ltd. (co-development and distribution agreement)
04

Financials

Market cap
$202.2M
Total revenue
$0
Enterprise value
$77M

Beyond the preview

Go deeper on Palisade Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Palisade Bio.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call